Chronic kidney disease

K Kalantar-Zadeh, TH Jafar, D Nitsch, BL Neuen… - The lancet, 2021 - thelancet.com
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …

Obesity and outcomes in COVID-19: when an epidemic and pandemic collide

F Sanchis-Gomar, CJ Lavie, MR Mehra, BM Henry… - Mayo Clinic …, 2020 - Elsevier
Obesity has reached epidemic proportions in the United States and in much of the
westernized world, contributing to considerable morbidity. Several of these obesity-related …

KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease

PE Stevens, SB Ahmed, JJ Carrero… - Kidney …, 2024 - kidney-international.org
This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis

X Shu, T Lin, H Wang, Y Zhao, T Jiang… - Journal of cachexia …, 2022 - Wiley Online Library
There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐
stage renal disease patients undergoing dialysis. This review aimed to summarize the …

Obesity in the critically ill: a narrative review

M Schetz, A De Jong, AM Deane, W Druml… - Intensive care …, 2019 - Springer
Abstract The World Health Organization defines overweight and obesity as the condition
where excess or abnormal fat accumulation increases risks to health. The prevalence of …

Why primary obesity is a disease?

A De Lorenzo, S Gratteri, P Gualtieri… - Journal of translational …, 2019 - Springer
Obesity must be considered a real pathology. In the world wide, obesity represent one of the
major public health issue associated with increased morbidity and mortality. Overweight or …

Obesity paradox: fact or fiction?

S Simati, A Kokkinos, M Dalamaga… - Current Obesity …, 2023 - Springer
Abstract Purpose of Review Obesity is related to several comorbidities such as type 2
diabetes mellitus, cardiovascular disease, heart failure, and various types of cancers. While …

Obesity, sleep apnea, and cancer

I Almendros, MA Martinez-Garcia, R Farré… - International Journal of …, 2020 - nature.com
The interest on a potential association between cancer and sleep-disordered breathing
(SDB) has clearly gained substantial traction over the last several years. This novel …

Obesity impact on SARS-CoV-2 infection: pros and cons “obesity paradox”—a systematic review

DM Vulturar, CB Crivii, OH Orăsan, E Palade… - Journal of clinical …, 2022 - mdpi.com
Background: During the last years, the COVID-19 pandemic meets the pandemic generated
by obesity, raising many questions regarding the outcomes of those with severe forms of …

Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 …

S Verma, DK McGuire, SC Bain… - Diabetes, Obesity …, 2020 - Wiley Online Library
Associations between body mass index (BMI) and the cardiovascular (CV) and kidney
efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in patients with type 2 …